3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
17
Lung Neoplasms
7
Small Cell Lung Carcinoma
5
Neoplasms
4
Carcinoma, Hepatocellular
4
Carcinoma
4
Urinary Bladder Neoplasms
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Cholangiocarcinoma
3
Neoplasms by Site
2
Neoplasms by Histologic Type
2
Liver Neoplasms
2
Gallbladder Neoplasms
2
Endometrial Neoplasms
2
Bile Duct Neoplasms
2
Vaccinia
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Resectable Intrahepatic Cholangiocarcinoma
1
Renal Pelvis and Ureter Urothelial Carcinoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Non-Small Cell Lung Cancer Metastatic
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms, Glandular and Epithelial
1
Mouth Neoplasms
1
Liver Diseases
1
Laryngeal Neoplasms
1
Hypopharyngeal Neoplasms
1
Interventions
nilotinib
1
Paclitaxel
1
Laparoscopy
1
Electrocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
durvalumab
×
30 days
×
Clear all
No trials found.